Literature DB >> 11518512

Regulation of prostate branching morphogenesis by activin A and follistatin.

B Cancilla1, R A Jarred, H Wang, S L Mellor, G R Cunha, G P Risbridger.   

Abstract

Ventral prostate development occurs by branching morphogenesis and is an androgen-dependent process modulated by growth factors. Many growth factors have been implicated in branching morphogenesis including activins (dimers of beta(A) and beta(B) subunits); activin A inhibited branching of lung and kidney in vitro. Our aim was to examine the role of activins on prostatic development in vitro and their localization in vivo. Organ culture of day 0 rat ventral prostates for 6 days with activin A (+/- testosterone) inhibited prostatic branching and growth without increasing apoptosis. The activin-binding protein follistatin increased branching in vitro in the absence (but not presence) of testosterone, suggesting endogenous activins may reduce prostatic branching morphogenesis. In vivo, inhibin alpha subunit was not expressed until puberty, therefore inhibins (dimers of alpha and beta subunits) are not involved in prostatic development. Activin beta(A) was immunolocalized to developing prostatic epithelium and mesenchymal aggregates at ductal tips. Activin beta(B) immunoreactivity was weak during development, but was upregulated in prostatic epithelium during puberty. Activin receptors were expressed throughout the prostatic epithelium. Follistatin mRNA and protein were expressed throughout the prostatic epithelium. The in vitro evidence that activin and follistatin have opposing effects on ductal branching suggests a role for activin as a negative regulator of prostatic ductal branching morphogenesis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518512     DOI: 10.1006/dbio.2001.0364

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  27 in total

1.  Activin A, a product of fetal Leydig cells, is a unique paracrine regulator of Sertoli cell proliferation and fetal testis cord expansion.

Authors:  Denise R Archambeault; Humphrey Hung-Chang Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

2.  Overexpression of follistatin in the mouse epididymis disrupts fluid resorption and sperm transit in testicular excurrent ducts.

Authors:  Darcie D Seachrist; Emhonta Johnson; Christianne Magee; Colin M Clay; James K Graham; D N Rao Veeramachaneni; Ruth A Keri
Journal:  Biol Reprod       Date:  2012-08-23       Impact factor: 4.285

3.  BMP7 inhibits branching morphogenesis in the prostate gland and interferes with Notch signaling.

Authors:  Irina B Grishina; Sung Yup Kim; Christopher Ferrara; Helen P Makarenkova; Paul D Walden
Journal:  Dev Biol       Date:  2005-12-15       Impact factor: 3.582

Review 4.  Cellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.

Authors:  Leanne M Cotton; Moira K O'Bryan; Barry T Hinton
Journal:  Endocr Rev       Date:  2008-01-23       Impact factor: 19.871

Review 5.  Molecular signaling pathways that regulate prostate gland development.

Authors:  Gail S Prins; Oliver Putz
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

Review 6.  Physical activity and its mechanistic effects on prostate cancer.

Authors:  A Wekesa; M Harrison; R W Watson
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-24       Impact factor: 5.554

Review 7.  Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.

Authors:  Roxanne Toivanen; Michael M Shen
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

Review 8.  TGF-β Family Signaling in Ductal Differentiation and Branching Morphogenesis.

Authors:  Kaoru Kahata; Varun Maturi; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-03-01       Impact factor: 10.005

9.  Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer.

Authors:  Yifei Tang; Wenying Yan; Jiajia Chen; Cheng Luo; Antti Kaipia; Bairong Shen
Journal:  BMC Syst Biol       Date:  2013-10-16

Review 10.  Follistatin as potential therapeutic target in prostate cancer.

Authors:  Maria Vittoria Sepporta; Francesca Maria Tumminello; Carla Flandina; Marilena Crescimanno; Marco Giammanco; Maurizio La Guardia; Danila di Majo; Gaetano Leto
Journal:  Target Oncol       Date:  2013-03-01       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.